Schedule 13G ownership disclosure

INOVIO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 45773H201

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,185,639
Percent of class
5.4200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-018351
Form type
SC 13G/A
Filer
INOVIO PHARMACEUTICALS, INC.
CIK
CIK 1055726
Filed
Feb 10, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub